The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShield Thera Share News (STX)

Share Price Information for Shield Thera (STX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.35
Bid: 2.30
Ask: 2.40
Change: -0.05 (-2.08%)
Spread: 0.10 (4.348%)
Open: 2.45
High: 2.50
Low: 2.35
Prev. Close: 2.40
STX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

DIRECTOR DEALINGS SUMMARY: New U&I Group CEO Upton Buys Shares

Thu, 21st Jan 2021 20:12

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Thursday and not separately reported by Alliance News:

----------

U&I Group PLC - London-based property regeneration developer and investor - Chief Executive Officer Richard Upton buys 108,000 shares at an average price of 68.5p each. Upton was promoted to role of CEO on Tuesday following a stint as chief development officer. U&I Group on Tuesday set itself a 100-day deadline for a strategic review led by Upton that will look ways to simplify and refocus the business toward more predictable income streams.

----------

IG Group Holdings PLC - London-based contract-for-difference provider - Chair Mike McTighe buys 3,100 shares at 827.9 pence each, for GBP25,665.

----------

Shield Therapeutics PLC - Newcastle, England-based pharmaceutical firm focussed on iron deficiency - Chair Hans Peter Hasler buys 100,000 shares at 59p each, which is his only holding.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
26 Feb 2021 10:32

AIM WINNERS & LOSERS: K3 Business Rises On Starcom Technologies Sale

AIM WINNERS & LOSERS: K3 Business Rises On Starcom Technologies Sale

Read more
29 Jan 2021 18:26

TRADING UPDATES: Character Extends Peppa Pig Deal; Dekel Raises Cash

TRADING UPDATES: Character Extends Peppa Pig Deal; Dekel Raises Cash

Read more
19 Jan 2021 15:04

DIRECTOR DEALINGS: Shield Therapeutics CEO Buys 100,000 Shares

DIRECTOR DEALINGS: Shield Therapeutics CEO Buys 100,000 Shares

Read more
15 Jan 2021 13:11

IN BRIEF: Shield Therapeutics Expects Increase In Annual Revenue

IN BRIEF: Shield Therapeutics Expects Increase In Annual Revenue

Read more
14 Dec 2020 16:59

UK DIRECTOR DEALINGS SUMMARY: Tracsis CFO Sells GBP480,000 In Shares

UK DIRECTOR DEALINGS SUMMARY: Tracsis CFO Sells GBP480,000 In Shares

Read more
11 Dec 2020 16:40

IN BRIEF: Shield Therapeutics Shares Drop As Eyes US Push On Its Own

IN BRIEF: Shield Therapeutics Shares Drop As Eyes US Push On Its Own

Read more
19 Oct 2020 17:34

IN BRIEF: Shield Therapeutics Notes Teva Withdrawing Patent Opposition

IN BRIEF: Shield Therapeutics Notes Teva Withdrawing Patent Opposition

Read more
19 Oct 2020 09:12

Shield shares rise as Teva withdraws patent oppositions

(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics updated the market on its opposition proceedings with Teva Pharmaceutical Industries on Monday, confirming that Teva had withdrawn its appeal and opposition over two of Shield's patents.

Read more
16 Sep 2020 11:13

Shield Therapeutics Swings To Profit As It Makes Feraccru Progress

Shield Therapeutics Swings To Profit As It Makes Feraccru Progress

Read more
7 Aug 2020 06:56

IN BRIEF: Shield Therapeutics' Product Offers Alternative For Anaemia

IN BRIEF: Shield Therapeutics' Product Offers Alternative For Anaemia

Read more
16 Jul 2020 21:19

IN BRIEF: Shield Therapeutics Notes PT20 Paper Publication

IN BRIEF: Shield Therapeutics Notes PT20 Paper Publication

Read more
26 Jun 2020 17:19

UK EXECUTIVE CHANGE SUMMARY: John Menzies Chief Executive Steps Down

UK EXECUTIVE CHANGE SUMMARY: John Menzies Chief Executive Steps Down

Read more
11 Jun 2020 16:17

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
3 Jun 2020 15:57

Shield Therapeutics shares rise on two recent research papers

(Sharecast News) - Commercial stage pharmaceutical company Shield Therapeutics reported the recent publication of two papers concerning its 'Feraccru' or 'Accrufer' product on Wednesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.